Research
-
Establishing the Moorfields Glaucoma BioResource to predict glaucoma development and personalise care
Researchers funded by Fight for Sight and Glaucoma UK are establishing a world-leading glaucoma bioresource of linked clinical and genetic data, allowing researchers to develop prediction models for personalised glaucoma treatment.
CompletedJuly 2021 - July 2022 -
What happens after trachoma infection to transform cells into scar tissue?
Aiming to understand why brief infections can cause years of disease
CompletedOctober 2012 - September 2015 -
How does sight loss affect quality of life in children and young people?
Developing age-appropriate tools for patient-led healthcare
CompletedJanuary 2013 - April 2018 -
Development of novel antimicrobial therapy for Acanthamoeba Keratitis
Researchers seek to develop novel HDPs with enhanced efficacy and safety to treat Acanthamoeba Keratitis (AK).
CompletedApril 2021 - May 2023 -
The effect of inflammation throughout the body on AMD
Could looking at what’s happening outside the retina in long-term illness shed light on a new approach to treating age-related macular degeneration?
CompletedOctober 2013 - September 2016 -
Making a vital component of gene therapy for retinitis pigmentosa that can be used in clinical trials
Improving on a treatment that works well in animals with a natural form of severe sight loss
CompletedOctober 2013 - September 2016 -
Can a moving target help to make the most of peripheral vision?
Exploring new ideas for visual aids to improve life for people with AMD
CompletedOctober 2013 - September 2016 -
Repairing the retina’s blood supply before sight-threatening damage occurs
Developing a better alternative to anti-VEGF drugs
CompletedDecember 2013 - February 2017 -
How do cell recycling, inflammation and support cell death link together in dry AMD?
Understanding more about a substance that might proect against wet AMD and also cause the dry form.
CompletedOctober 2013 - September 2016